<code id='DC44474AFC'></code><style id='DC44474AFC'></style>
    • <acronym id='DC44474AFC'></acronym>
      <center id='DC44474AFC'><center id='DC44474AFC'><tfoot id='DC44474AFC'></tfoot></center><abbr id='DC44474AFC'><dir id='DC44474AFC'><tfoot id='DC44474AFC'></tfoot><noframes id='DC44474AFC'>

    • <optgroup id='DC44474AFC'><strike id='DC44474AFC'><sup id='DC44474AFC'></sup></strike><code id='DC44474AFC'></code></optgroup>
        1. <b id='DC44474AFC'><label id='DC44474AFC'><select id='DC44474AFC'><dt id='DC44474AFC'><span id='DC44474AFC'></span></dt></select></label></b><u id='DC44474AFC'></u>
          <i id='DC44474AFC'><strike id='DC44474AFC'><tt id='DC44474AFC'><pre id='DC44474AFC'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:2
          Sen. Bob Menendez (D-N.J.) Michael M. Santiago/Getty Images

          WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry could see one of its historical, and increasingly rare, Democratic allies ousted from Congress.

          The New Jersey senator is embroiled in another financial scandal after last week’s indictment over hundreds of thousands of dollars he and his wife allegedly accepted to influence military aid. The charges — which Menendez insists he will beat — come roughly seven years after he was accused of pressuring Medicare officials to resolve a dispute in favor of a lavish political donor. That case ended in a hung jury.

          advertisement

          But this time around, Capitol lawmakers and New Jersey Democrats including Sen. Cory Booker, a longtime legislation partner, are calling on Menendez to resign. The mounting pressure and looming court battle spell out a hazy future for one of the pharmaceutical industry’s biggest allies in the Democratic Party.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          Eli Lilly, Pfizer, and others want in on the online prescription market
          Eli Lilly, Pfizer, and others want in on the online prescription market

          MikeReddyforSTATSincethepandemic,patientshavebecomeincreasinglycomfortablewithgettingtheirmedication

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          Why doctors need education on FDA device approval process

          AdobeInherfinalpresentationforhealthpolicyclassattheUniversityofChicago,first-yearmedicalstudentRobi